Market Place
Sourcing Support
ProtoKinetix Successfully Completes PI Trials for T1D
20 Jul 2022 //
BUSINESSWIRE
ProtoKinetix Announces Selection of AAGP® Candidate Formulat Dry Eye Disease
23 Nov 2021 //
PRESS RELEASE
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
23 Nov 2021 //
PRESS RELEASE
ProtoKinetix & IQVIA Partner to Support Development of AAGP Product
12 May 2021 //
BUSINESSWIRE
ProtoKinetix Announces the Resumption of Phase 1b Trials for the use of AAGP®
22 Apr 2021 //
BUSINESSWIRE
Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived
24 Nov 2020 //
BUSINESSWIRE
ProtoKinetix AAGP® Restores Vision in Blind Test Subjects
15 Sep 2020 //
BIOSPACE
American BriVision Conducts Site Monitoring Visit PhII Part I Trial for ABV-1505
06 Apr 2020 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.